FDA Update
The U.S. Food and Drug Administration (FDA) has published a presentation on ongoing activities of the FDA. It also intends to show how changes in FDA regulations and actions could affect pharmaceutical industry's practice. The following tasks are covered:
- FDA mission
- Approval and actions
- Drug safety information
- Safe Use Initiative
- REMS/Medication Guides
- Patient Medication Information (PMI)
- Sentinel Initiative
- OTC News
- Recalls
- Drug shortages
- Supply chain integrity
Get more in the presentation "FDA Update".
Related GMP News
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan
19.08.2026FDA: Simplified Registration for U.S. Sites and Greater Complexity for Non-U.S. Sites
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?